Literature DB >> 22179849

Changes in blood metabolic parameters during the development of Walker-256 tumour-induced cachexia in rats are not caused by decreased food intake.

Priscila Cassolla1, Carolina Campos Lima Moreira, Thaís Fernanda Liboni, Cássia Thaïs Bussamra Vieira Zaia, Glaucia Regina Borba-Murad, Roberto Barbosa Bazotte, Helenir Medri de Souza.   

Abstract

Blood metabolic parameters of Walker-256 tumour-bearing rats, on days 5, 8, 11 and 14 after implantation of tumour, were compared with those of rats without tumour fed ad libitum (free-fed control) or with reduced feeding (pair-fed control), similar to the anorexic tumour-bearing rats. Cachexia parameters and tumour mass also were investigated. In general, especially on day 14 after implantation of tumour, there was reduction of body mass, gastrocnemius muscle mass, food intake and glycemia and increase of blood triacylglycerol, free fatty acids, lactate and urea, compared with free-fed controls rats. These changes did not occur in pair-fed control, except a slight reduction of glycemia. Pair-fed control showed no significant changes in blood cholesterol and glycerol in comparison with free-fed control, although there was reduction of cholesterol and increase of blood glycerol on day 14 after tumour implantation compared with pair-fed control. The results demonstrate that, besides the characteristic signs of the cachexia syndrome such as anorexia, weight loss and muscle catabolism, Walker-256 tumour-bearing rats show several blood metabolic alterations, some of which begin as early as day 5 after implantation of tumour, and are accentuated during the development of cachexia. Evidence that the alterations of blood metabolic parameters of tumour-bearing rats were not found in pair-fed control indicate that they were not caused by decreased food intake. These changes were probably mediated by factors produced by tumour or host tissue in response to the presence of tumour.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22179849     DOI: 10.1002/cbf.2792

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  8 in total

1.  Early treatment with metformin induces resistance against tumor growth in adult rats.

Authors:  Amanda B Trombini; Claudinéia Cs Franco; Rosiane A Miranda; Júlio C de Oliveira; Luiz F Barella; Kelly V Prates; Aline A de Souza; Audrei Pavanello; Ananda Malta; Douglas L Almeida; Laize P Tófolo; Kesia P Rigo; Tatiane As Ribeiro; Gabriel S Fabricio; Juliane R de Sant'Anna; Marialba Aa Castro-Prado; Helenir Medri de Souza; Hely de Morais; Paulo Cf Mathias
Journal:  Cancer Biol Ther       Date:  2015-05-29       Impact factor: 4.742

2.  Effects of celecoxib and ibuprofen on metabolic disorders induced by Walker-256 tumor in rats.

Authors:  Camila Oliveira de Souza; Mirian Ayumi Kurauti; Flaviane de Fatima Silva; Hely de Morais; Glaucia Regina Borba-Murad; Fábio Goulart de Andrade; Helenir Medri de Souza
Journal:  Mol Cell Biochem       Date:  2014-10-31       Impact factor: 3.396

3.  Insulin secretion decline in Walker-256 tumor-bearing rats is early, follows the course of cachexia, and is not improved by lixisenatide.

Authors:  Débora Luiza Quintilhano; Daniele Romani Miksza; Winny Beatriz de Souza Galia; Mahira Oliveira Ramalho Costa Ramalho; Camila Ferraz Lucena; Maíra Mello Rezende Valle; Maria Fernanda Rodrigues Graciano; Helenir Medri de Souza; Gisele Lopes Bertolini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-31       Impact factor: 3.000

4.  Changes in liver gluconeogenesis during the development of Walker-256 tumour in rats.

Authors:  Carolina Campos Lima Moreira; Priscila Cassolla; Ana Paula Segantini Dornellas; Hely de Morais; Camila Oliveira de Souza; Glaucia Regina Borba-Murad; Roberto Barbosa Bazotte; Helenir Medri de Souza
Journal:  Int J Exp Pathol       Date:  2013-02       Impact factor: 1.925

5.  Walker 256 tumor-bearing rats demonstrate altered interstitial cells of Cajal. Effects on ICC in the Walker 256 tumor model.

Authors:  L Fracaro; F C V Frez; B C Silva; G E Vicentini; S R G de Souza; H A Martins; D R Linden; F A Guarnier; J N Zanoni
Journal:  Neurogastroenterol Motil       Date:  2015-11-03       Impact factor: 3.598

6.  Pioglitazone treatment increases survival and prevents body weight loss in tumor-bearing animals: possible anti-cachectic effect.

Authors:  Mércia Beluzi; Sidney B Peres; Felipe S Henriques; Rogério A L Sertié; Felipe O Franco; Kaltinaitis B Santos; Pâmela Knobl; Sandra Andreotti; Cláudio S Shida; Rodrigo X Neves; Stephen R Farmer; Marília Seelaender; Fábio B Lima; Miguel L Batista
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

Review 7.  Pathophysiology of anorexia in the cancer cachexia syndrome.

Authors:  Chukwuemeka Charles Ezeoke; John E Morley
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-10-27       Impact factor: 12.910

8.  Aerobic Exercise Training Attenuates Tumor Growth and Reduces Insulin Secretion in Walker 256 Tumor-Bearing Rats.

Authors:  Veridiana Mota Moreira; Claudinéia Conationi da Silva Franco; Kelly Valério Prates; Rodrigo Mello Gomes; Ana Maria Praxedes de Moraes; Tatiane Aparecida Ribeiro; Isabela Peixoto Martins; Carina Previate; Audrei Pavanello; Camila Cristina Ianoni Matiusso; Douglas Lopes Almeida; Flávio Andrade Francisco; Ananda Malta; Laize Peron Tófolo; Sandra da Silva Silveira; Lucas Paulo Jacinto Saavedra; Katia Machado; Paulo Henrique Olivieri da Silva; Gabriel S Fabrício; Kesia Palma-Rigo; Helenir Medri de Souza; Flaviane de Fátima Silva; Giuliana Regina Biazi; Taís Susane Pereira; Elaine Vieira; Rosiane Aparecida Miranda; Júlio Cezar de Oliveira; Luiz Delmar da Costa Lima; Wilson Rinaldi; Maria Ida Ravanelli; Paulo Cezar de Freitas Mathias
Journal:  Front Physiol       Date:  2018-05-08       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.